Breaking News, Collaborations & Alliances

WuXi STA, Ark Biosciences Sign CMC Devt. & Mfg. Deal

The CDMO will provide Ark with integrated services for in process R&D and manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec, and Ark Biosciences, a global biotech focusing on drug discovery and development, especially in the area of viral infection and respiratory disease, have entered a strategic partnership for CMC development and manufacturing.   Under the terms of the collaboration, Ark Biosciences will utilize the Marketing Authorization Holder (MAH) scheme to accelerate drug development and WuXi STA will provide an integrated solution in process R&amp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters